Lifecore Biomedical, Inc. \De\ Q1 FY2026 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2026 Q1 Call date: 2025-11-06 Concluded

Quarter scorecard

Revenue

$31.11M

+25.9% YoY

Diluted EPS

$-0.29

Gross margin

25.0%

+3.2 pp YoY

Net income

-$9.99M

Contract Development and Manufacturing Organization $21.75M

+7.8%

HA Manufacturing $9.36M

+106.9%